Metronidazole (Bacterial Vaginosis)
Brand names: Flagyl, Zidoval (vaginal gel)
This entry covers metronidazole used specifically for bacterial vaginosis, available as an oral course or as an intravaginal gel, both first-line options for symptomatic infection.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It is reduced within anaerobic organisms to reactive intermediates that damage microbial DNA, eradicating the anaerobic overgrowth (including Gardnerella) that characterises bacterial vaginosis.
Prescribing in practice
- Counsel that systemic exposure from oral therapy (and to a lesser extent the gel) produces a disulfiram-like reaction with alcohol, so alcohol should be avoided during and just after treatment.
- Recurrence is common, and the intravaginal gel offers an option with fewer systemic side effects for women who do not tolerate oral therapy.
- Vaginal preparations may weaken latex condoms and diaphragms, reducing their contraceptive reliability.
Monitoring
No routine laboratory monitoring is needed; assess symptomatic response and consider testing for co-existing sexually transmitted infections.
Counselling the patient
- Avoid alcohol during the course and for a short time afterwards.
- Latex condoms and diaphragms may be damaged by vaginal preparations, so they cannot be relied on for contraception during use.
- Return if symptoms persist or recur, as bacterial vaginosis can come back.
Evidence & guidelines
BASHH guidance recommends oral or intravaginal metronidazole as first-line treatment for symptomatic bacterial vaginosis.
Reference: BASHH BV Guideline 2021; NICE CKS Bacterial Vaginosis; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- DOAC Score for Selecting Direct Oral Anticoagulant in Non-Valvular AF · Anticoagulation
- Weight-Based Levothyroxine Dose Calculator · Thyroid
- Centor / McIsaac Score for Strep Pharyngitis · Throat
- Spontaneous Bacterial Peritonitis (SBP) Diagnosis · Diagnostic
- Ho Index for Predicting Response to Medical Therapy in IBD · Inflammatory Bowel Disease
- Deauville Score (5-Point Scale) for Lymphoma Response · Treatment Response
- Spinal Anaesthesia Hypotension Management · AAGBI; ASA
- Pre-Eclampsia / Eclampsia in ED · NICE NG133; RCOG Green-top 10A
- Suspected Ectopic Pregnancy · NICE NG126; RCOG Green-top 21
- Polycystic Ovary Syndrome (PCOS) · International PCOS Guideline 2023; NICE CKS
- Pre-eclampsia Management · NICE NG133 2019
- Ectopic Pregnancy · NICE CG154 / RCOG GTG 21